Consultations – Page 7 – BIVDA Newsletter

Consultations Consultations Archive Membership News Membership News Archive

Consultation: Role of incentive schemes in general practice

The Government is seeking views on the role of incentives in general practice – members may wish to comment on the lack of incentives around the use of diagnostics and how incentivisation could aid patient care and pathways. If you intend to send feedback, we would appreciate if you could also send it to us so that we can incorporate…

DawnJanuary 17, 2024

Consultations Consultations Archive

Digital pulmonary rehabilitation technologies for adults with chronic obstructive pulmonary disease: early value assessment

The consultation documents for the above Early Value Assessment are now publicly available here. Also available at the same link is a copy of the committee papers, which include the Early Value Assessment Report. Comments can be submitted using the consultation comments table at the same link. Please return your comments by 10 January 2024 by 5.00pm If you…

Ben KempDecember 21, 2023

Consultations Consultations Archive

NICE: Meningitis (bacterial) and meningococcal disease update

Tell us about the 5 key areas for quality improvement which you consider as having the greatest potential to improve the quality of care in this area. Closing date for comments: Wednesday 20 December 2023 at 5pm You can access the website here.

Ben KempDecember 15, 2023

Consultations Consultations Archive

ISO/PWI 24884 Electronic Instructions for Use for In Vitro Diagnostic Medical Devices (Minimum required information and means of delivery)

Scope The proposed new standard provides guidelines on the conditions (means of delivery) and minimum required information which shall be physically delivered, when providing electronic instructions for use (eIFU) for in vitro diagnostic medical devices (IVDs). Not in the scope of this standard: The content of the eIFU as it is covered by ISO 18113-1, -2, -3, -4, -5. This…

DawnDecember 1, 2023

Consultations Consultations Archive

ISO/PWI TS 24883 Lateral flow immunoassay for rapid diagnostic testing — General guideline for test performance

Scope This document provides the general principles and guideline for the rapid diagnostic testing (RDT) of LFIA used for the In vitro diagnostics as follows: — Design and development of LFIA — General guideline for test performance of LFIA — Recommendations for the use of LFIA This document is specific to the RDT of LFIA, which employ the gold nanoparticle…

DawnDecember 1, 2023

Consultations Consultations Archive

Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node positive early breast cancer

NICE's diagnostics guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34) makes recommendations on tumour profiling tests for oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer. This guidance will assess use of the tests for ER-positive, HER2-negative cancer that has spread to the…

DawnNovember 17, 2023

Consultations Consultations Archive

Call for Evidence – National Security and Investment Act

Call for evidence description The Government will use this Call for Evidence to consider changes to the NSI regime. We are looking for views from cross economy stakeholders both in the UK and overseas. In particular, this evidence will help the Government: Hone the scope of the system’s mandatory notification requirements; Improve NSI notification and assessment processes; and Develop the…

DawnNovember 17, 2023

Consultations Consultations Archive External Affairs Working Party External Affairs Working Party Archive Infectious Diseases Working Party Infectious Diseases Working Party Archive Regulatory Affairs Working Party Regulatory Affairs Working Party Archive

NICE guideline on suspected sepsis – consultation

This NICE guideline covers suspected sepsis: recognition, diagnosis and early management – source control, rapid antigen tests, indicators of organ hypoperfusion, intravenous fluids, and vasopressors in the NEWS2 population. You can now comment on this draft scope. The scope defines what the guideline will (and will not) cover. The consultation closes at 5pm, Thursday 23 November 2023.

DawnNovember 10, 2023